Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

A.F.Y.R.E.N. Aktie 113722499 / FR0014005AC9

09.12.2025 07:50:03

EQS-News: AFYREN and ESSE Skincare begin partnership to offer 100% natural cosmetic solutions with enhanced skincare performance

EQS-News: AFYREN SAS / Key word(s): Alliance
AFYREN and ESSE Skincare begin partnership to offer 100% natural cosmetic solutions with enhanced skincare performance

09.12.2025 / 07:50 CET/CEST
The issuer is solely responsible for the content of this announcement.


AFYREN and ESSE Skincare begin partnership to offer 100% natural cosmetic solutions with enhanced skincare performance

  • First application of bio-based propionic acid brings new potential for skin health and sustainable cosmetic solutions
  • Propionic acid has benefits for microbiome preservation and skin balance
  • Bio-based propionic acid is produced via natural fermentation at the AFYREN NEOXY plant in France

Clermont-Ferrand/Lyon, December 9, 2025, 07:45 am CET - AFYREN, a greentech company offering manufacturers biobased, low-carbon ingredients through a unique fermentation technology based on a completely circular model, and South Africa-based Esse Skincare, a leader in microbiome skincare science, are partnering to introduce the world’s first bio-based propionic acid for the skincare industry.

Propionic acid is a naturally occurring short chain fatty acid essential for maintaining a balanced skin microbiome. Emerging research suggests it helps modulate inflammation, support barrier resilience, and maintain microbial balance – key to hydrated, resilient skin.

Until now, propionic acid has only been available at industrial scale from petrochemical sources. Through this partnership, Esse gains access to AFYREN’s sustainably produced, COSMOS-certified, bio-based alternative propionic acid made at AFYREN NEOXY, the company’s flagship industrial biorefinery. Using AFYREN’s proprietary circular, low-carbon fermentation process, the plant is the first in the world capable of producing a portfolio of organic acids at commercial scale.

Our collaboration with AFYREN allows us to use a natural microbial metabolite in its pure, bio-based form – a first for the skincare industry,” said the late Trevor Steyn, founder of Esse, reflecting the pioneering vision that continues to guide our innovation. “This agreement represents a significant step toward creating formulations that work in harmony with the skin’s natural ecosystem, opening the door to new cosmetic solutions that stay true to this principle.

Nicolas Sordet, CEO of Afyren, said: “This shows how biotechnology can unlock new opportunities for both performance and sustainability in cosmetics that bring real benefits to humans and the environment. We look forward to seeing the first products reach consumers.”

Together, Esse and Afyren are shaping a new generation of skincare products - one that merges biotechnology, sustainability, and proven skin science.

About ESSE Skincare

Esse Skincare is a leader in professional microbiome skincare. Certified organic, carbon neutral, and cruelty-free, Esse partners with skin professionals in over 40 countries to deliver science-backed products and treatments that rebalance the skin microbiome and optimize long-term skin health.

Find out more: www.esseskincare.com

About AFYREN

AFYREN is a French greentech company, founded in 2012, focused on providing innovative, sustainable solutions to reduce reliance on fossil-based resources. AFYREN’s proprietary, nature-inspired fermentation technology valorizes local biomass from non-food agricultural co-products to produce 100% biobased, low-carbon carboxylic acids. The company’s sustainable solutions address decarbonization challenges in a wide variety of strategic sectors, including human and animal nutrition, flavors and fragrances, life sciences, materials science, plus lubricants and technical fluids. AFYREN’s competitive, plug-and-play, circular technology enables manufacturers to adopt sustainable solutions without modifying production processes.

The company’s first industrial plant, AFYREN NEOXY, a joint venture with Bpifrance's SPI fund, is based in the Grand-Est region of France, serving primarily the European market. AFYREN is also pursuing a project in Thailand with a global leader in the sugar industry and is building its presence in the Americas, based on existing distribution agreements.

At the end of 2024, AFYREN employed 130 people across sites in Lyon, Clermont-Ferrand and Carling Saint-Avold. Committed to continuous innovation, the company invests 20% of its annual budget in R&D to further develop the range of sustainable solutions.

AFYREN is listed on Euronext Growth® Paris since 2021 (ISIN code: FR0014005AC9, ticker: ALAFY).

For more information, visit www.afyren.com and follow us on LinkedIn.

Contacts

AFYREN
Director for ESG, Communications and Public Affairs
Caroline Petigny
caroline.petigny@afyren.com
 
Investor Relations
Mark Reinhard
invest@afyren.com
 
 
 
NewCap
 
Investor Relations
Théo Martin / Mathilde Bohin
Tel: +33 1 44 71 94 94
afyren@newcap.eu
 
Media Relations
Nicolas Mérigeau / Gaëlle Fromaigeat
Tel: +33 1 44 71 94 98
afyren@newcap.eu
MC Services AG (international)
 
Investor Relations
Bettina Ellinghorst
 
Media Relations
Shaun Brown, Dr. Johanna Kobler
Tel: +49 89 210 228 0
afyren@mc-services.eu

 



09.12.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2241760  09.12.2025 CET/CEST

Analysen zu A.F.Y.R.E.N.

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Krypto-Crash oder Einstiegs-Chance? – Bernhard Wenger von 21Shares zu Gast im BX Morningcall

Im BX Morningcall spricht Krypto-Experte Bernhard Wenger von @21shares über seinen Weg vom klassischen ETF-Geschäft in die Welt der Krypto-ETPs und erklärt, warum Bitcoin & Co. längst nicht ausgereizt sind. Er beleuchtet den Wandel von einem vorwiegend retailgetriebenen Markt hin zu immer mehr institutionellen Investoren, die über regulierte, physisch besicherte Produkte wie Bitcoin- und Krypto-ETPs investieren. Themen sind unter anderem Volatilität und „Krypto-Winter“, strenge Compliance- und Geldwäschereiregeln, Kostenstrukturen, Unterschiede im DACH-Raum sowie die Rolle des neuen US-Bitcoin-ETFs und des strategischen Investors FalconX für die nächste Wachstumsphase von 21Shares.

👉🏽 https://bxplus.ch/bx-musterportfolio/

Krypto-Crash oder Einstiegs-Chance? – Bernhard Wenger von 21Shares zu Gast im BX Morningcall

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’483.37 19.97 B9GSAU
Short 13’773.58 13.81 SI9BRU
Short 14’292.86 8.83 B94SVU
SMI-Kurs: 12’931.16 09.12.2025 17:31:24
Long 12’413.35 19.38 SAKBZU
Long 12’135.26 13.66 S0CB8U
Long 11’625.67 8.95 BH2SIU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com